Veeva SystemsWBO:VEEV +5.25%88 ROA % is 11.55% as of Apr. 2026, which is 3% below its 10-year median of 11.89. GuruFocus rates WBO:VEEV with a GF Score™ of 88/100 and a GF Value™ of €246.73 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 683 Healthcare Providers & Services companies, Veeva Systems ranks better than 89.46% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Veeva Systems's annualizedNet Income for the quarter that ended in Apr. 2026 was €892 Mil.
Veeva Systems's average Total Assets over the quarter that ended in Apr. 2026 was €7,724 Mil. Therefore, Veeva Systems's annualized ROA % for the quarter that ended in Apr. 2026 was 11.55%.
The historical rank and industry rank for Veeva Systems's ROA % or its related term are showing as below:
WBO:VEEV'
s ROA % Range Over the Past 10 Years
Min: 9.56 Med: 11.89 Max: 15.94
Current: 11.22
During the past 13 years, Veeva Systems's highest ROA % was 15.94%. The lowest was 9.56%. And the median was 11.89%.
WBO:VEEV's ROA % is ranked better than 89.46% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.77
vs WBO:VEEV: 11.22
Veeva Systems (WBO:VEEV) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Apr. 2026) net income data. The Revenue data used here is four times the quarterly (Apr. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Veeva Systems ROA % Related Terms
Veeva Systems ROA % Historical Data
* Premium members only.
The historical data trend for Veeva Systems's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's ROA % distribution charts can be found below:
* The bar in red indicates where Veeva Systems's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Veeva Systems (WBO:VEEV) has a ROA % of 11.55% as of Apr. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Veeva Systems and its competitors. This is near median its historical median of 11.89. Over the past decade, Veeva Systems' ROA % has ranged from 9.56 to 15.94. According to the industry distribution chart, Veeva Systems ranks #72 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 10.5%.
Is Veeva Systems' ROA % too high?
Veeva Systems' current ROA % of 11.55% is near median its 10-year median of 11.89. Over the past 10 years, this metric has ranged from a low of 9.56 to a high of 15.94. The Healthcare Providers & Services industry median ROA % is 1.77. Veeva Systems' value of 11.55% is 552.5% above this industry median. Based on the distribution chart, Veeva Systems ranks #72 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' ROA % compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #72 out of 683 companies for ROA %. This places Veeva Systems in the top 11% of its industry — outperforming the majority of peers. The industry median ROA % is 1.77. Veeva Systems' value of 11.55% is 552.5% above this benchmark. Historically, Veeva Systems' own ROA % has ranged from 9.56 to 15.94 over the past decade. While the company's 10-year median is 11.89 vs. the industry median of 1.77, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current ROA % of 11.55% is 552.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current ROA % is 11.55%, which is near median its own 10-year median of 11.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (WBO:VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is €246.73, compared to a current price of €148.25 — trading 39.9% below its estimated fair value. The current ROA % is 11.55%, which is near median its 10-year median of 11.89 and 552.5% above the Healthcare Providers & Services industry median of 1.77. Veeva Systems' overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Veeva Systems (WBO:VEEV), the current ROA % is 11.55% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (WBO:VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of €148.25 is trading 39.9% below its estimated GF Value™ of €246.73.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for WBO:VEEV:
ROA %: 11.55% (near median its 10-year median of 11.89)
GF Value™: €246.73 vs. price of €148.25 (39.9% below fair value)
Industry Position: 552.5% above the Healthcare Providers & Services median (#72 of 683)
No single metric tells the full story. See the WBO:VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
88GF Score
Get the complete analysis for WBO:VEEV
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:VEEV has been successfully added to your 
